Doug F Kling

Title: Doug F Kling: Innovator in Antifungal Treatments

Introduction

Doug F Kling is a notable inventor based in Lebanon, NJ (US). He has made significant contributions to the field of medicine, particularly in the development of antifungal treatments. His innovative work focuses on enhancing the delivery of antifungal compounds to the central nervous system.

Latest Patents

Doug F Kling holds a patent for "Encholeated antifungal compounds for central nervous system delivery and treatment of infections." This patent describes a cochleate composition that includes one or more cochleates and at least two antifungal compounds selected from a range of effective agents, including amphotericin B, fluconazole, and voriconazole. The patent also discloses methods for using these antifungal cochleate formulations, which could potentially revolutionize treatment options for patients with central nervous system infections.

Career Highlights

Doug F Kling is associated with Matinas Biopharma Nanotechnologies, Inc., where he applies his expertise in nanotechnology to develop advanced pharmaceutical solutions. His work at the company emphasizes the importance of innovative drug delivery systems in improving patient outcomes.

Collaborations

Some of Doug's notable coworkers include Raphael J Mannino and Ruying Lu. Their collaborative efforts contribute to the ongoing research and development of effective antifungal therapies.

Conclusion

Doug F Kling's contributions to antifungal treatments highlight the importance of innovation in the medical field. His patent and work at Matinas Biopharma Nanotechnologies, Inc. demonstrate a commitment to improving healthcare through advanced technology.